Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Laura D Attardi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-1782-9045; OpenAlex author ID A5019574388; NIH RePORTER profile ID 1885021. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 4)
Trials
0
Grants
3
Labs led
1
Collaborators
53
Papers, trials and grants by year

2013: 1 grant · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper, 1 grant · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 1 grant · 2026: 4 papers

Papers 11

  1. DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines. Co-author DOI 10.1016/j.canlet.2026.218666↗
  2. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-026-04234-8↗
  3. Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment. Last author DOI 10.1158/0008-5472.can-25-1969↗
  4. Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment. First author DOI 10.1172/jci200909↗
  5. Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state. Co-author DOI 10.1038/s41419-024-06460-9↗
  6. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. Co-author DOI 10.1038/s41467-024-54761-6↗
  7. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-024-03054-y↗
  8. Multifaceted role for p53 in pancreatic cancer suppression. Last author DOI 10.1073/pnas.2211937120↗
  9. Cell of Origin Influences Pancreatic Cancer Subtype. Last author DOI 10.1158/2159-8290.cd-20-0633↗
  10. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Last author DOI 10.1016/j.ccell.2017.09.007↗
  11. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3952↗

Grants 3

  1. Administrative and Biostatistics Core P01CA244114↗
  2. Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis R35CA197591↗
  3. Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio R21CA169673↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sofia Ferreira · 6 shared papers, 2023–2026 · strength 1.62
  2. Mara H. Sherman · 1 shared paper, 1 shared grant, 2025–2026 · strength 0.79
  3. Brittany M. Flowers · 5 shared papers, 2017–2026 · strength 0.76
  4. Walter Gwang-Up Park · 1 shared paper, 1 shared grant, 2024–2025 · strength 0.73
  5. Stephano S. Mello · 5 shared papers, 2015–2026 · strength 0.59
  6. Laura DeLong Wood · 4 shared papers, 2017–2026 · strength 0.58
  7. Garry Nolan · 1 shared grant, 2025 · strength 0.57
  8. Seung K Kim · 1 shared grant, 2025 · strength 0.57
  9. Steven E Artandi · 1 shared grant, 2025 · strength 0.57
  10. Edgar G. Engleman · 1 shared grant, 2025 · strength 0.57
  11. Pawel Karol Mazur · 4 shared papers, 2015–2026 · strength 0.54
  12. Marija Trajkovic‐Arsic · 3 shared papers, 2015–2026 · strength 0.37
  13. Mert Erkan · 3 shared papers, 2015–2026 · strength 0.37
  14. Bence Sipos · 3 shared papers, 2015–2026 · strength 0.37
  15. Julien Sage · 3 shared papers, 2015–2026 · strength 0.37
  16. Irina Heid · 3 shared papers, 2015–2026 · strength 0.37
  17. Stephan A. Hahn · 3 shared papers, 2015–2026 · strength 0.37
  18. Alexander Herner · 3 shared papers, 2015–2026 · strength 0.37
  19. Roland Michael Schmid · 3 shared papers, 2015–2026 · strength 0.37
  20. Jens Thomas Siveke · 3 shared papers, 2015–2026 · strength 0.37
  21. Iréne Esposito · 3 shared papers, 2015–2026 · strength 0.37
  22. Elisabeth Heßmann · 3 shared papers, 2015–2026 · strength 0.37
  23. Jorg H. Kleeff · 3 shared papers, 2015–2026 · strength 0.37
  24. Simone Hausmann · 3 shared papers, 2015–2026 · strength 0.37
  25. Rickmer Braren · 3 shared papers, 2015–2026 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.